5 not yet recruiting, 1 completed, 1 recruiting. 3 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Not yet recruiting 2, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Hepatic Encephalopathy (HE): new trials by email Literature Review of Hepatic Encephalopathy (HE) trials Research Report on Hepatic Encephalopathy (HE)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RENEW: Study of Porcine Liver Support in Participants With Acute-on-Chronic Liver Failure metra® Extracorporeal Liver Cross-Circulation (ELC) system (OrganOx), EGEN-5784 (genetically engineered porcine liver) - Acute on Chronic Liver Failure (ACLF), Hepatic Encephalopathy (HE) | Phase 1 / Phase 2 | Not yet recruiting | eGenesis, INC | 20 | 2026-10-01 | 2026-09-21 |
| Equivalence of Electronic vs Paper-based PHES in Diagnosing Hepatic Encephalopathy Paper-based PHES, Electronic PHES - Liver Cirrhosis, Hepatic Encephalopathy (HE) | Not applicable | Not yet recruiting | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 80 | 2026-10-01 | 2026-10-14 |
| UDCA to Prevent Post-TIPS Hepatic Encephalopathy Ursodeoxycholic Acid (UDCA), Lactulose - Hepatic Encephalopathy (HE), TIPS | Not applicable | Not yet recruiting | West China Hospital | 270 | 2026-01-01 | 2025-12-09 |
| Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE) Cirrhoses, Liver, Hepatic Encephalopathy (HE) | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 32 | 2025-09-01 | 2025-09-25 | |
| 7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy 7.0T MRI-Scan - Hepatic Encephalopathy (HE), MRI | Not yet recruiting | Chinese PLA General Hospital | 200 | 2025-04-03 | 2025-04-11 | |
| Underdilated-stent Technique Improves Post-TIPS Encephalopathy 6mm balloon dilation, 8mm balloon dilation - Liver Cirrhosis, Variceal Bleeding, Cirrhosis | Not applicable | Recruiting | The Second Affiliated Hospital of Chongqing Medical University | 72 | 2024-11-19 | 2026-01-20 |
| MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) MNK6106, Rifaximin - Hepatic Cirrhosis, Hepatic Encephalopathy (HE) | Phase 2 | Completed | Mallinckrodt | 50 | 2018-12-01 | 2021-07-20 |
Hepatic Encephalopathy (7) · Liver Cirrhosis (3) · Acute-On-Chronic Liver Failure (1) · Fibrosis (1)
Brain Diseases (7) · Brain Diseases, Metabolic (7) · Central Nervous System Diseases (7) · Digestive System Diseases (7) · Hepatic Insufficiency (7) · Liver Diseases (7) · Liver Failure (7) · Metabolic Diseases (7) · Nervous System Diseases (7) · Nutritional and Metabolic Diseases (7) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Fibrosis (2) · Liver Failure, Acute (1)
Drug Delivery Systems (1) · Drug Evaluation (1) · Lactulose (1) · Rifaximin (1) · Ursodeoxycholic Acid (1)
Chinese PLA General Hospital (1) · Mallinckrodt (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1) · The First Affiliated Hospital with Nanjing Medical University (1) · The Second Affiliated Hospital of Chongqing Medical University (1) · West China Hospital (1) · eGenesis, INC (1)
China (4) · United States (2) · Puerto Rico (1)
Wenfang Cheng (1) · Xin Lou (1)
PMID 14762784, PMID 18775022, PMID 20036625, PMID 22321469, PMID 24480619, PMID 25042402, PMID 25316553, PMID 25735521, PMID 26614596, PMID 28506905, PMID 28512687, PMID 28690175, PMID 29485654, PMID 30643936, PMID 30940552, PMID 33524293, PMID 33621635, PMID 35266571, PMID 35289658, PMID 35667296, PMID 35821274, PMID 37178732, PMID 37606572, PMID 37926635, PMID 38349709, PMID 38492132, PMID 39181214, PMID 39565434, PMID 39864468, PMID 39962750, PMID 40097036, PMID 40348497, PMID 40436647, PMID 40615853